Md. Code Regs. 10.47.07.05-1

Current through Register Vol. 51, No. 22, November 1, 2024

Section 10.47.07.05-1 - Disclosure of Naloxone Medication Data

Disclosure of Naloxone Medication Data for Public Health Surveillance, Research, Analysis, Education, and Public Reporting.

A. The Program shall disclose naloxone medication data for research, analysis, education, and public reporting:

(1) Upon approval by the Department of a written proposal or abstract explaining the purpose and scope of the research, analysis, education, and public reporting; and

(2) After redaction of all information that could identify a patient, prescriber, dispenser, or any other individual.

B. The Secretary may waive the requirement of §A(1) of this regulation for requests from units of the Department.

C. The Program may disclose de-identified naloxone medication data for public health surveillance purposes.

D. The Program may not disclose identifiable naloxone medication data to any entity, including but not limited to prescribers or dispensers.

Md. Code Regs. 10.47.07.05-1

Regulation .05-1 adopted effective 50:8 Md. R. 337, eff. 7/20/2023